Month: January 2025

MONTREAL, Jan. 14, 2025 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) is pleased to announce the appointment of Audrey Bouchard, CPA Auditor, as the Company’s Chief Financial Officer, effective immediately. “We are delighted to have Audrey join us as Prime embarks on its next phase of growth,” said Alexandre Côté, President and CEO of Prime. “She has a remarkable entrepreneurial spirit as well as extensive financial accounting experience gained at one of the most prestigious accounting firms. These skills will be extremely valuable for our future projects and financial governance.” Audrey Bouchard has more than 14 years of experience in financial accounting, including at Econofitness since 2021, where she held the position of Director of Finance and Accounting, and at PwC from 2011 to...

Pairing Adaptive Biotechnologies’ clonoSEQ MRD results with NeoGenomics’ COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment continuum SEATTLE and FORT MYERS, Fla., Jan. 14, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, and NeoGenomics, Inc. (Nasdaq:NEO), a leading oncology testing services company, today announced a multi-year exclusive strategic commercial collaboration that will advance minimal residual disease (MRD) monitoring options for patients with select blood cancers. Adaptive’s next-generation sequencing (NGS)-based clonoSEQ® is the first and only FDA-cleared in vitro...

MONTRÉAL, Jan. 14, 2025 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the fourth quarter and full year 2024 on February 6, 2025. Financial results for the fourth quarter and full year 2024 Éric Martel, President and Chief Executive Officer, Bombardier, and Bart Demosky, Executive Vice President and Chief Financial Officer, Bombardier, will present the financial results for the fourth quarter and full year 2024 in a live presentation, followed by a question-and-answer period with analysts.   The presentation will take place on February 6, 2025, at 8:00 a.m. ET. To listen in:  Live webcast (recommended):  A live webcast of the financial results presentation, along with the relevant financial charts, will be available on this webpage.By phone:  The presentation can also be accessed by telephone....

Digital Colocation Monthly Revenue grew 69% Y/Y from December 2023 Total Current Operating Hash Rate (EH) about 4.98 EH/s and expected to grow to about 5.10 EH/s given new developments announced in early January 2025 Recently Executed 20 MW Digital Asset Colocation Agreement with New Enterprise-Grade Customer Current Total Operating Capacity of 129 MW, expected to grow to 153 MW upon Ohio facility completion later in 2025 MIDLAND, Pa., Jan. 14, 2025 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or “the Company”), a publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (AI), high-performance computing (HPC), and digital assets markets, today announced its unaudited business and operational update for December 2024. Rahul Mewawalla, CEO and President...

Dr. Arturo Gomez Appointed as Vice President of Engineering Aduro Expands Marketing Initiatives with Outside The Box Capital LONDON, Ontario, Jan. 14, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announces key developments in its commercialization journey. As the Company prepares to commission its Hydrochemolytic™ Technology (HCT) pilot plant in Q3 2025, Aduro has appointed Dr. Arturo Gomez as Vice President of Engineering and entered into a new marketing agreement with Outside The Box Capital (“OTBC”). Dr. Arturo Gomez as Vice President of Engineering: Arturo’s career...

H&R Block combines 70 years of trusted expertise with cutting-edge technology and unparalleled support to ensure hardworking Americans get every dollar they deserve at tax time KANSAS CITY, Mo., Jan. 14, 2025 (GLOBE NEWSWIRE) — With e-file set to open on Jan. 27, H&R Block (NYSE: HRB) is arming taxpayers with the latest information regarding significant changes to tax laws, deductions and credits that could impact individual returns, and the resources needed to minimize tax liabilities and receive their maximum refund – guaranteed. As the pioneer of the tax preparation category 70 years ago, H&R Block is trusted by more than 20 million hardworking Americans each year to ensure the best possible outcome at tax time with less stress by combining the latest technology that enables individuals to file how and when...

OLNEY, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc. (Nasdaq: SASR) will release its fourth quarter earnings for 2024 on Tuesday, January 28, 2025. About Sandy Spring Bancorp, Inc.Sandy Spring Bancorp, Inc., headquartered in Olney, Maryland, is the holding company for Sandy Spring Bank, a premier community bank in the Greater Washington, D.C. region. With over 50 locations, the bank offers a broad range of commercial and retail banking, mortgage, private banking, and trust services throughout Maryland, Virginia, and Washington, D.C. Through its subsidiaries, Rembert Pendleton Jackson  and West Financial Services, Inc., Sandy Spring Bank also offers a comprehensive menu of wealth management services. Source: Sandy Spring Bancorp, Inc. For additional information or questions, please contact:  Daniel J. Schrider,...

311 subjects enrolled across various stages of loading and randomization in SOL-R, Ocular’s second registrational trial of AXPAXLI™ in wet AMD, as of January 10, 2024 First wet AMD registrational trial, SOL-1, completed randomization in December 2024 with topline data anticipated in Q4 2025 Company plans to seek FDA feedback in H1 2025 on clinical trial design for AXPAXLI in NPDR BEDFORD, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina experience, outlined exceptional clinical progress across its registrational program for AXPAXLI™ in wet age-related macular degeneration (wet AMD), plans to advance AXPAXLI in non-proliferative diabetic retinopathy (NPDR), and the Company’s strategic outlook for...

WILMINGTON, Del., Jan. 14, 2025 (GLOBE NEWSWIRE) — Ashland Inc. (NYSE: ASH) today announced plans to issue its first-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, January 28, 2025. The company’s live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, January 29. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be:Guillermo Novo, chair, and chief executive officer Kevin Willis, senior vice president and chief financial officer Dago Caceres, senior vice president, general manager, specialty additives Alessandra Faccin, senior vice president, general manager,...